ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors
Partnership combines ARTBIO's AlphaDirectTM platform for 212Pb-based alpha radioligand therapies with 3B Pharmaceuticals...